The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies

• Liqiang Li,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft

  Affiliation School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China

  ⨯
• Su Wang ,

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: wangsu414@163.com (SW); chenyuwen@syphu.edu.cn (YC)

  Affiliations School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China, Drug Regulatory Research Base of NMPA, Research Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Shenyang, China

  ⨯
• Yuwen Chen

  Roles Conceptualization, Project administration, Supervision, Writing – review & editing

  * E-mail: wangsu414@163.com (SW); chenyuwen@syphu.edu.cn (YC)

  Affiliations School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China, Drug Regulatory Research Base of NMPA, Research Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Shenyang, China

  https://orcid.org/0000-0003-1804-4653

  ⨯